Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Francesca Maria Tanca"'
Autor:
Daniele Santini, Giuseppe Procopio, Camillo Porta, Toni Ibrahim, Sandro Barni, Calogero Mazzara, Andrea Fontana, Alfredo Berruti, Rossana Berardi, Bruno Vincenzi, Cinzia Ortega, Davide Ottaviani, Giacomo Carteni, Gaetano Lanzetta, Vladimir Virzì, Matteo Santoni, Nicola Silvestris, Maria Antonietta Satolli, Elena Collovà, Antonio Russo, Giuseppe Badalamenti, Stefano Luzi Fedeli, Francesca Maria Tanca, Vincenzo Adamo, Evaristo Maiello, Roberto Sabbatini, Alessandra Felici, Saverio Cinieri, Giuseppe Tonini, Sergio Bracarda
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83026 (2013)
BackgroundBone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC.Patients and methodsData on clinicopatho
Externí odkaz:
https://doaj.org/article/89f1cff242564bc3a6ef30e3f7975439
Autor:
Gaetano Lanzetta, Giovanni Mansueto, Michelle Sterpi, Francesco Ferraù, Antonio Russo, Giuseppe Badalamenti, Marco Russano, Francesca Maria Tanca, Bruno Vincenzi, Filippo de Marinis, Nicla La Verde, Raffaele Addeo, Alfredo Falcone, Elena Collovà, Davide Ottaviani, Toni Ibrahim, Flavia Longo, Daniele Santini, Sandro Barni, Maria Antonietta Satolli, Enrico Vasile, Salvatore Intagliata, Fausto Petrelli, L. Ginocchi, Giuseppe Tonini, Vincenzo Adamo, Cinzia Ortega, Luca Moscetti, Francesco Pantano, Flavia Cantile, Andrea Mancuso, Domenico Galetta
Publikováno v:
Scientific Reports. 6
Scientific Reports 5: Article number: 18670; published online: 22 December 2015; updated: 15 April 2016. The original version of this Article contained errors in the spelling of the authors Daniele Santini, Sandro Barni, Salvatore Intagliata, Alfredo
Publikováno v:
Expert Opinion on Pharmacotherapy. 10:1359-1366
Medroxyprogesterone acetate (MPA) is a synthetic, orally active derivative of the natural steroid hormone progesterone, widely used in oncology both in the endocrine treatment of hormone-related cancers and as supportive therapy in the cachexia syndr
Autor:
Elena Massa, Roberto Serpe, Francesca Maria Tanca, Clelia Madeddu, Giorgio Astara, Antonio Macciò, Filomena Panzone, Giorgia Antoni, Giovanni Mantovani
Publikováno v:
Mediterranean Journal of Nutrition and Metabolism. 2:29-36
Cancer-related anorexia/cachexia syndrome (CACS) is a multifactorial syndrome characterised by tissue wasting, particularly lean body mass (LBM), metabolic alterations, fatigue, anorexia and reduced food intake. In April 2005 we started a phase III r
Autor:
Michelle Sterpi, Maria Antonietta Satolli, Salvatore Intagliata, Toni Ibrahim, L. Ginocchi, Bruno Vincenzi, Vincenzo Adamo, Raffaele Addeo, Alfredo Falcone, Filippo de Marinis, Giuseppe Badalamenti, Cinzia Ortega, Antonio Russo, Nicla La Verde, Flavia Longo, Daniele Santini, Gaetano Lanzetta, Davide Ottaviani, Giovanni Mansueto, Enrico Vasile, Flavia Cantile, Francesco Ferraù, Fausto Petrelli, Giuseppe Tonini, Elena Collovà, Francesca Maria Tanca, Sandro Barni, Luca Moscetti, Francesco Pantano, Andrea Mancuso, Domenico Galetta, Marco Russano
We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor bone involvement in Non-Small Cell Lung Cancer.Data on clinical-pathology, skeletal outcomes and bone-directed therapies for 661 deceased patients with evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4112664c062c31532e09ed5a9deb363
http://hdl.handle.net/10447/200704
http://hdl.handle.net/10447/200704
Autor:
Williams, Bart O., Daniele, Santini, Giuseppe, Procopio, Camillo, Porta, Toni, Ibrahim, Sandro, Barni, Calogero, Mazzara, Andrea, Fontana, Berruti, Alfredo, Rossana, Berardi, Bruno, Vincenzi, Cinzia, Ortega, Davide, Ottaviani, Giacomo, Carteni, Gaetano, Lanzetta, Vladimir, Virzì, Matteo, Santoni, Nicola, Silvestris, Maria Antonietta Satolli, Elena, Collovà, Antonio, Russo, Giuseppe, Badalamenti, Stefano Luzi Fedeli, Francesca Maria Tanca, Vincenzo, Adamo, Evaristo, Maiello, Roberto, Sabbatini, Alessandra, Felici, Saverio, Cinieri, Giuseppe, Tonini, Sergio, Bracarda
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 12, p e83026 (2013)
PLoS ONE, Vol 8, Iss 12, p e83026 (2013)
BackgroundBone metastasis represents an increasing clinical problem in advanced renal cell carcinoma (RCC) as disease-related survival improves. There are few data on the natural history of bone disease in RCC.Patients and methodsData on clinicopatho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3f7374ca924135aadb32d1444fade1e
http://hdl.handle.net/10447/104475
http://hdl.handle.net/10447/104475
Autor:
Roberto Serpe, M.C. Cau, Clelia Madeddu, Filomena Panzone, Giorgio Astara, L. Montaldo, Mariele Dessì, Marco Mura, Antonio Macciò, Giorgia Antoni, Giovanni Mantovani, Francesca Maria Tanca, Quirico Mela
Publikováno v:
Clinical nutrition (Edinburgh, Scotland). 31(2)
Summary Background & aims A phase III, randomized non-inferiority study was carried out to compare a two-drug combination (including nutraceuticals, i.e. antioxidants) with carnitine + celecoxib ± megestrol acetate for the treatment of cancer-relate
Autor:
Roberto Serpe, Filomena Panzone, Francesca Maria Tanca, Clelia Madeddu, Giovanni Mantovani, Elena Massa, Giulia Gramignano, Eleonora Sanna, Mariele Dessì, Laura Deiana, Antonio Macciò, Paolo Contu, Carlo Floris
Publikováno v:
Nutrition (Burbank, Los Angeles County, Calif.). 24(4)
Objective In April 2005 a phase III randomized study was started to establish which was the most effective and safest treatment of cancer-related anorexia/cachexia syndrome and oxidative stress in improving identified primary endpoints: increase of l
Autor:
C. Spiga, Elena Massa, Francesca Maria Tanca, Elena Patteri, Giovanni Mantovani, Michela Pisano, Giorgio Astara, Clelia Madeddu, Laura Deiana, Eleonora Sanna, Ilaria Puddu, Giovanna Lamonica, Federica Saba
Publikováno v:
Critical reviews in oncology/hematology. 66(1)
Objectives To establish a correlation between a specific MGA category, an appropriate preventively established treatment and clinical outcome in a population of elderly cancer patients. The ultimate goal was to verify whether the appropriate treatmen
Publikováno v:
Annals of Oncology. 23:ix516-ix517
Background We designed a case-control phase II open, prospective non-randomized trial in elderly “fit” (≥65 yo) cancer patients (pts) compared to well-matched adult (45-65 yo) cancer pts to assess whether the same standard antineoplastic treatm